| | Identification | Back Directory |  | [Name] 
 HYODEOXYCHOLIC ACID SODIUM SALT
 |  | [CAS] 
 10421-49-5
 |  | [Synonyms] 
 SODIUM HYODEOXYCHOLATE
 hyodeoxycholic acid sodium
 Extracts from the lock Yang
 Cynomorium songaricum Rupr.
 Cynomorium songaricum extract
 HYODEOXYCHOLIC ACID SODIUM SALT
 Songaria Cynomorium Herb Extract
 Sodium hyodeoxycholate≥ 98% (Assay)
 (3a,6a)-3,6-Dihydroxycholan-24-oic acid
 Sodium 3α,6α-dihydroxy-5β-cholan-24-oate
 HYODEOXYCHOLIC ACID SODIUM SALT10421-49-5
 3α,6α-Dihydroxy-5β-cholan-24-oic acid sodium salt
 5BETA-CHOLAN-24-OIC ACID-3ALPHA,6ALPHA-DIOL SODIUM SALT
 3ALPHA,6ALPHA-DIHYDROXY-5BETA-CHOLAN-24-OIC ACID SODIUM SALT
 3,6-dihydroxy-,monosodiumsalt,(3alpha,5beta,6alpha)-cholan-24-oicaci
 3α,6α-Dihydroxy-5β-cholan-24-oic  acid,  Hyodeoxycholic  acid  sodium  salt
 3alpha,6alpha-Dihydroxy-5beta-cholan-24-oic Acid Sodium Salt
Hyodeoxycholic Acid Sodium Salt
 |  | [EINECS(EC#)] 
 1806241-263-5
 |  | [Molecular Formula] 
 C24H39NaO4
 |  | [MDL Number] 
 MFCD00079342
 |  | [MOL File] 
 10421-49-5.mol
 |  | [Molecular Weight] 
 414.55
 | 
 | Hazard Information | Back Directory |  | [Chemical Properties] 
 White to almost white powder
 |  | [Uses] 
 It is used as pharmaceutical intermediate. Benzoylthiophenes are allosteric enhancers (AE) of agonist activity at the A1 adenosine receptor.
 |  | [in vivo] 
 
 Hyodeoxycholic acid (HDCA; 1.25% (wt/wt)) sodium obviously decreases fat mass and increases lean mass but does not raise the serum levels of any organ toxicity markers in LDLRKO mice. Hyodeoxycholic acid inhibits atherosclerotic lesion formation in LDLRKO at multiple sites, improves plasma lipoprotein profiles, decreases plasma glucose level and intestinal cholesterol absorption efficiency and increases daily cholesterol excretion through fecal output. Hyodeoxycholic acid sodium also improves HDL function as measured by a cholesterol efflux assay[2]. |  | [IC 50] 
 Microbial Metabolite; Human Endogenous Metabolite
 | 
 |  |